OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 07, 2016
The assay will provide information on biosimilar comparability.
July 06, 2016
Novo Nordisk broke ground on an expanded production plant for insulin in Kalundborg, Denmark.
Teligent is expanding its manufacturing and R&D complex in New Jersey.
July 02, 2016
Integrating quality and compliance with technology transfer and careful project management are key in starting up a facility and launching a biologic drug.
Early planning for the integration of clean-in-place systems for equipment cleaning is key.
Aseptic spray drying provides an alternative to lyophilization as an enabling stabilization technology for parenteral biologic formulations.
July 01, 2016
A study by MilliporeSigma and the Economist Intelligence Unit reviews growth drivers and approaches to mitigate risk.
June 30, 2016
The drug received breakthrough therapy and orphan drug designation as a monotherapy for the treatment of chronic graft-versus-host-disease.
June 28, 2016
Antibodies to dengue may either confer protective immunity to the Zika virus or enhance disease severity in secondary, related infections such as Zika.
MilliporeSigma and the International Vaccine Institute in Seoul, South Korea aim to develop more robust, scalable vaccine manufacturing processes.